Equity Overview
Price & Market Data
Price: $14.10
Daily Change: -$0.45 / 3.19%
Daily Range: $14.08 - $15.24
Market Cap: $703,715,584
Daily Volume: 265,078
Performance Metrics
1 Week: -3.65%
1 Month: -10.48%
3 Months: 12.81%
6 Months: 108.3%
1 Year: 63.28%
YTD: -7.52%
Company Details
Employees: 30
Sector: Health technology
Industry: Biotechnology
Country:
Details
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. It also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.